Invictus RG’s Medifast MED Stock Holding History

Invictus RG’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,380	Closed	-$527K	–	86
2018 Q3	$527K	Buy	2,380 +358	+18%	+$72.6K	0.4%	59
2018 Q2	$324K	Sell	2,022 -933	-32%	-$119K	0.27%	100
2018 Q1	$276K	Buy	+2,955	New	+$221K	0.18%	166

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invictus RG's MED Position: Q4 2018 in Review

Invictus RG sold out of Medifast (MED) in Q4 2018, closing a stake of 2,380 shares — an estimated $527K sold.

Invictus RG first reported a position in MED in Q1 2018 and held it in 3 quarters. The position peaked at $527K in Q3 2018. 247 funds tracked by Wall St. Rank hold MED as of Q4 2018.

Invictus RG reported no remaining Medifast position as of Q4 2018 after selling out during the quarter.
Invictus RG sold 2,380 Medifast shares in Q4 2018, an estimated $527K.
Invictus RG first reported a position in Medifast in Q1 2018 and held it in 3 quarters.
Invictus RG's Medifast position peaked at $527K in Q3 2018.
247 funds tracked by Wall St. Rank held Medifast as of Q4 2018.

Based on Invictus RG's 13F filing for Q4 2018, filed 13 Feb 2019.